11.07.2015 Views

Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Richtlijn</strong>: <strong>Erfelijke</strong> <strong>darmkanker</strong> (<strong>1.0</strong>)152 - Holloway SHolloway S, Porteous M, Cetnarskyj R, Rush R, Appleton S, Gorman D et al. Referrals of patients tocolorectal cancer genetics services in south-east Scotland. Fam Cancer 2005;4:151-61.153 - Hookey LCHookey LC, Depew WT, Vanner SJ. A prospective randomized trial comparing low-dose oral sodiumphosphate plus stimulant laxatives with large volume polyethylene glycol solution for colon cleansing. Am JGastroenterol 2004;99:2217-22.154 - Houlston RSHoulston RS, Murday V, Harocopos C, Williams CB, Slack J. Screening and genetic counselling forrelatives of patients with colorectal cancer in a family cancer clinic. BMJ 1990;301:366-8.155 - Hsu CWHsu CW, Imperiale TF. Meta-analysis and cost comparison of polyethylene glycol lavage versus sodiumphosphate for colonoscopy preparation. Gastrointest Endosc 1998;48:276-82.156 - Stracham TStracham T, Read AP, Human Molecular Genetics. red. Garland Publishing, London, New York, 2004157 - Huppertz-Hauss GHuppertz-Hauss G, Bretthauer M, Sauar J, Paulsen J, Kjellevold O, Majak B, et al. Polyethylene glycolversus sodium phosphate in bowel cleansing for colonoscopy: a randomized trial. Endoscopy2005;37:537-41.158 - Hwang KLHwang KL, Chen WT, Hsiao KH, Chen HC, Huang TM, Chiu CM, et al. Prospective randomizedcomparison of oral sodium phosphate and polyethylene glycol lavage for colonoscopy preparation. World JGastroenterol 2005;11:7486-93.159 - Iida MIida M, Yao T, Itoh H, Watanabe H, Matsui T, Iwashita A et al. Natural history of gastric adenomas inpatients with familial adenomatous coli/ Gardner´s syndrome. Cancer 1988;61:605-11.160 - Jablonska MJablonska M, Reznikova L, Kotrlik J, Svitavsky M, Mikova M, Tabach J. Clinical implications of recognitionof the hereditary non-polyposis colon cancer syndrome (HNPCC) for the early detection of colorectalcancer. Sb Lek 1995;96:275-82.161 - James ASJames AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening amongAfrican Americans in North Carolina: how does perception relate to screening behavior? Cancer EpidemiolBiomarkers Prev 2002;11:529-34.162 - Janinis JJaninis J, Patriki M, Vini L, Ara<strong>van</strong>tinos G, Whelan JS. The pharmacological treatment of aggressivefibromatosis: a systematic review. Ann Oncol 2003;14:181-90.163 - Järvinen HJJärvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditarynonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.164 - Järvinen HJJärvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P et al. Controlled 15-yeartrial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.03/11/08 <strong>Erfelijke</strong> <strong>darmkanker</strong> (<strong>1.0</strong>) 98

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!